1st Quarter - Report

FOLEY HOAG LLP for SPECTRUM PHARMACEUTICALS

Firm
Client
Income
$15,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA authority for notification of drug shortages; S. 296 Preserving Access to Life-Saving Medications Act

LobbyistCovered position, as disclosed
BRIAN CAREY New Professional staff, Senate Committee on Labor, and Human Resources
PAUL KIM New Senator Kennedy Director For Health Policy;, Congressman Waxman counsel; Senator Pryor, Staff
STACEY SACHS New Health Counsel to the U.S. Senate Committee, on Health, Education, Labor and Pensions

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 296 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.